Celebrating the 10th Annual Lurie Prize in Biomedical Sciences
This year, the Lurie Prize in Biomedical Sciences recognized the outstanding achievements of two researchers studying the aging process, each of whose work has paralleled and complemented the other’s over the past 20 years. Both winners of the 10th Annual Lurie Prize in Biomedical Sciences have achieved incredible milestones in biomedical science, and the FNIH is proud to honor their efforts.
The award included a $100,000 honorarium, split between the two winners and made possible by a donation to the FNIH by philanthropist Ann Lurie, President of the Ann and Robert H. Lurie Foundation, President of Lurie Holdings, Inc., and Honorary FNIH Board Member. Thank you, Ann, for making it possible for FNIH to power science and celebrate these accomplished researchers.
A distinguished jury of biomedical researchers, chaired by FNIH board member Solomon H. Snyder, MD, selected Anne Brunet, PhD, and Andrew Dillin, PhD, as this year’s winners.
2022 Award Recipients
Dr. Brunet employed a unique multi-organismal approach to investigate the ability of enzymes to regulate genes implicated in aging and has identified genes and pathways critical for maintaining neural stem cells that may help preserve brain function during aging. She noted:
“Using epigenetics, we and others have made the discovery that when you affect the specific enzymes, the specific molecules that are very important to make the cell’s DNA either accessible to do its job or inaccessible, this influences the entire lifespan of the organism. What it suggests is that regulating the expression of the DNA matters a lot.”
Andrew Dillin, PhD
Howard Hughes Medical Institute Investigator and the Thomas and Stacey Siebel Distinguished Chair in Stem Cell Research at the Department of Molecular and Cell Biology at the University of California, BerkeleyDr. Dillin explored the ability of organisms to sustain proper protein production processes essential to maintaining cellular structure and function in aging. Here’s what he shared of his experience:
“When we had first discovered that modulating mitochondrial function [in the cell] could profoundly change the lifespan of an organism, I thought every cell was going to contribute. But then it turned out that only a few cells contributed to aging, those in the nervous system. That was one of those moments when you thought – WOW! – these few cells control the mechanism of aging through mitochondria for the entire organism. That is really powerful.”